Dr. Rayaz Ahmed
Director
Cancer Care / Oncology, Bone Marrow Transplant, Hematology Oncology, Medical Oncology, Paediatric (Ped)/Medical Oncology, Haematology (Hematology)
Max Super Speciality Hospital, Saket
Max Smart Super Speciality Hospital, Saket
Max Hospital, Gurgaon
Share Doctor Profile
Select Hospital
About Dr. Rayaz Ahmed
- Experience of 17+ years, more than 1000 bone marrow transplants
- Senior Consultant, Department of Hematology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi
- Associate Professor, Department of Hematology, CMC Vellore
- MBBS, Pt. Ravi Shanker University, Raipur, C.G. India, 1999
- MD, Shivaji University Kolhapur, Maharashtra, 2003
- DM, Christian Medical College & Hospital, Vellore, Tamil Nadu, 2010
- Successfully Conducted Autologous, Allogeneic (MSD, MUD, Haplo)
- University Gold Medal in MD Pathology 2003, Shivaji University, Kolhapur, Maharashtra
- Autologous Stem Cell Transplant
- Allogeneic Stem Cell Transplant (Matched Sibling Donor Stem Cell Transplant)
- Haplo Identical Stem Cell Transplant
- Matched Unrelated Stem Cell Transplant
- Aplastic Anemia
- Thalassemia Treatment
- Sickle Cell Anemia
- Leukemia (AML/ ALL/ CML/CLL)
- Lymphoma (Hodgkin and Non-Hodgkin)
- Multiple Myeloma
- Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children
- Factors influencing adherence to imatinib in Indian chronic myeloid leukemia patients: a cross-sectional study
- V-raf murine sarcoma viral oncogene homolog B (BRAF) mutations in hairy cell leukaemia
- The use of a fludarabine-based conditioning regimen in patients with severe aplastic anemia--a retrospective analysis from three Indian centers
- Two novel missense mutations in iron transport protein transferrin causing hypochromic microcytic anaemia and haemosiderosis: molecular characterization and structural implications
- Outcome of treatment with a low cost protocol in adults with T cell acute lymphoblastic leukemia in a tertiary care center in India
- Improved clinical outcomes of high risk thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning regimen and peripheral blood stem cell grafts
- Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis
- Molecular basis of Wiskott-Aldrich syndrome in patients from India
- Carbonyl reductase 1 expression influences daunorubicin metabolism in acute myeloid leukemia
OPD Timings
- Monday: 4pm to 6pm
- Wednesday: 2pm to 4pm